James Langston
- Genetics top 1%
- Glioma Diagnosis and Treatment 11
- Neurology top 5%
- Neuroblastoma Research and Treatments 6
- Biotechnology top 2%
- Enzyme Production and Characterization 5
- Molecular Biology top 10%
-
- Brain Metastases and Treatment 3
-
- Biofuel production and bioconversion 5
-
- Meningioma and schwannoma management 3
-
- Advanced Cellulose Research Studies 2
-
- Ocular Oncology and Treatments 2
- Co-authors
- Feng XuAmar GajjarMatt SweeneyTarana ShaghasiEric AbbateElena VlasenkoPeter C. BurgerDeborah A. Lafond
- Cited by
- GeneticsNeurologyBiotechnology
- Journals
- Journal of Clinical Oncology (4 papers)Applied and Environmental Microbiology (1 paper)Biochemistry (2 papers)
- Partner nations
- United StatesUruguayDenmark
In The Last Decade
James Langston
25 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Genetics 887
- Neurology 435
- Biotechnology 224
- Molecular Biology 777
- Pulmonary and Respiratory Medicine 341
Countries citing papers authored by James Langston
This map shows the geographic impact of James Langston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Langston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Langston more than expected).
Fields of papers citing papers by James Langston
This network shows the impact of papers produced by James Langston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Langston. The network helps show where James Langston may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Langston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 22 | |
| 2 | 2011 | 320 | |
| 3 | 2009 | 77 | |
| 4 | 2007 | 12 | |
| 5 | Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastomabreakdown → | 2006 | 637 |
| 6 | 2006 | 68 | |
| 7 | 2005 | 39 | |
| 8 | 2004 | 62 | |
| 9 | 2000 | 8 | |
| 10 | 1999 | 56 | |
| 11 | 1998 | 47 | |
| 12 | 1997 | 33 | |
| 13 | 1995 | 46 | |
| 14 | 1995 | 37 | |
| 15 | 1995 | 17 | |
| 16 | 1994 | 65 | |
| 17 | 1994 | 46 | |
| 18 | 1993 | 36 | |
| 19 | 1993 | 50 | |
| 20 | 1991 | 50 |
About James Langston
James Langston is a scholar working on Genetics, Biotechnology and Neurology, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Neuroblastoma Research and Treatments (6 papers), Biofuel production and bioconversion (5 papers), Enzyme Production and Characterization (5 papers), Brain Metastases and Treatment (3 papers), Meningioma and schwannoma management (3 papers), Advanced Cellulose Research Studies (2 papers) and Ocular Oncology and Treatments (2 papers). The work is most often cited by research in Genetics (887 citations), Neurology (435 citations) and Biotechnology (224 citations). James Langston has collaborated with scholars based in United States, Uruguay and Denmark. Frequent co-authors include Feng Xu, Amar Gajjar, Matt Sweeney, Tarana Shaghasi, Eric Abbate, Elena Vlasenko, Peter C. Burger, Deborah A. Lafond, Karin M. Muraszko and Patricia L. Robertson. Their work appears in journals such as Journal of Clinical Oncology, Applied and Environmental Microbiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.